US OptionsDetailed Quotes

ATAI240719C1000

Watchlist

0.35
0.000.00%

15min DelayTrading Jul 1 13:55 ET

0.00High0.00Low

ATAI Life Sciences Stock Discussion

Trytosaveabit

Jun 20 06:05

Update

$ATAI Life Sciences(ATAI.US)$ atai Life Sciences Announces Update on Beckley Psytech's Phase 1/2a Trial of ELE-101 (IV Psilocin) for Major Depressive Disorder, with Initial Results from Phase 1 and First Patients Dosed in Phase 2a
4 MINUTES AGO, 7:00 AM EDT
VIA GLOBENEWSWIRE
• ELE-101 is a patent-protected, synthetic formulation of psilocin, designed to offer the therapeutic benefits of psilocybin in a more consistent, controllable, and shorter treatment paradigm of approximately two hour...

Jaguar8

Jun 20 06:01

NEWS

$ATAI Life Sciences(ATAI.US)$
atai Life Sciences Announces Update on Beckley Psytech’s Phase 1/2a Trial of ELE-101 (IV Psilocin) for Major Depressive Disorder, with Initial Results from Phase 1 and First Patients Dosed in Phase 2a
atai Life Sciences has provided an update on Beckley Psytech's Phase 1/2a trial of ELE-101 for Major Depressive Disorder (MDD). ELE-101 is a synthetic psilocin formulation designed for a consistent and shorter treatment duration of approximately two hours. The Phas...

Kevin Matte

Jun 2 13:42

Bullish signals & market sentiments !

$ATAI Life Sciences(ATAI.US)$ Descending triangle forming on an ancient important key level and positive divergences make us believe in a bullish feeling. The trading volume seems to be significant in these areas, but volume is missing. The Fibonnaci retracement seems to indicate a setback at 1.72, but a possible reversal at $1.42-1.45 could happen to... Anticipation of volatility increase and trading 'Options' suggest that market sentiment is bullish. Will t...

Trytosaveabit

Apr 24 06:15

Update

$ATAI Life Sciences(ATAI.US)$ Atai Life Sciences Disclosed Dosing Of First Patient In Part 2 Of Beckley Psytech's Phase 2a Study Exploring BPL-003 Adjunctive To SSRIs In Patients With Treatment Resistant Depression

Trytosaveabit

Apr 4 11:29

$ATAI Life Sciences(ATAI.US)$ Gap down from 2.63 to 1.50 has finally been completely filled today! Break upward past 2.85? And 3.10 with buy side pressure is next lvl

Trytosaveabit

Apr 4 08:56

$ATAI Life Sciences(ATAI.US)$ Still a lovely mover!

Trytosaveabit

Apr 3 11:36

What a beautiful chart! Read this and enjoy? Or ignore and you do you! Hehehe

$ATAI Life Sciences(ATAI.US)$ The 15 min tells you all you need to know, at least for now! Buy side is lovely HH’s and HL’s! Its a perfect chart for someone learning to read how/where to buy in using the 1/3/5 minute chart! And once you would take a position. Switch to the 5/10/15 minute chart to ride the trend! And I suggest using 7-8 or 9 EMA! Being honest here i use MA Instead of EMA! But the EMA does remove a bit of...

Trytosaveabit

Apr 3 10:09

$ATAI Life Sciences(ATAI.US)$

Trytosaveabit

Mar 28 15:14

Good info in here! Pay attention to some dates and make a note!

$ATAI Life Sciences(ATAI.US)$ Intranasal 5-MeO-DMT Clinical Trial Offers Hope For Treatment-Resistant Depression
Benzinga· 2 mins ago
Partners Beckley Psytech and atai Life Sciences (NASDAQ:ATAI) have jointly announced positive initial results from a Phase 2a study of Beckley's novel formulation of 5-MeO-DMT in Treatment Resistant Depression (TRD.)
See: Atai Invests $50M In Beckley Psytech For Short-Duration Psychedelics Development
...

Trytosaveabit

Mar 20 13:53

Update

$Clearmind Medicine(CMND.US)$ $Cybin(CYBN.US)$ $Bright Minds Biosciences(DRUG.US)$ $ATAI Life Sciences(ATAI.US)$ Psyched: LSD, Psilocybin As Breakthrough Therapies, $14M Fed Grant For Ibogaine, Indiana's Research And More
Benzinga· 2 mins ago

No comment yet